Immunovant Inc (NASDAQ:IMVT)

27.79
Delayed Data
As of Aug 10
 +0.59 / +2.17%
Today’s Change
8.34
Today|||52-Week Range
29.96
+75.11%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Immunovant Inc have a median target of 32.00, with a high estimate of 36.00 and a low estimate of 26.00. The median estimate represents a +15.15% increase from the last price of 27.79.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Immunovant Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.33
Sales
$0.00
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 13.68%
 
 
 
 
Growthannually 11.43%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.